Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04650893 · ClinicalTrials.gov registry record · Phase 3
The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF
A Phase 3 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 3
- Development phase
- 33
- Enrollment target
NCT04650893 is a Phase 3 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 33 participants.
The verdict
NCT04650893, a Phase 3 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study is to assess the efficacy of intra-operative intravenous non-steroidal anti-inflammatory drug (Ketorolac) versus intravenous (dexamethasone) administration on dysphagia and dysphonia after anterior cervical discectomy and fusion (ACDF).
Interventions
- DRUG Placebo
- DRUG Intravenous Dexamethasone
- DRUG Intravenous Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-01-02 |
| Est. Completion | 2023-12-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04650893
The ClinicalTrials.gov registry entry for NCT04650893 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04650893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04650893 about?
NCT04650893 is a clinical study titled "The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF". This study is to assess the efficacy of intra-operative intravenous non-steroidal anti-inflammatory drug (Ketorolac) versus intravenous (dexamethasone) administration on dysphagia and dysphonia after anterior cervical discectomy and fusion (ACDF).
What is the current status of trial NCT04650893?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 33 participants. The study started on 2021-01-02. Estimated completion is 2023-12-08.
What interventions are being tested in trial NCT04650893?
The interventions under investigation include: Placebo (DRUG), Intravenous Dexamethasone (DRUG), Intravenous Ketorolac (DRUG).
Who is sponsoring clinical trial NCT04650893?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.